The Role of Chemotherapy in Prostate Cancer

William Kevin Kelly, DO, discusses the role of chemotherapy in castration-resistant prostate cancer.

William Kevin Kelly, DO, professor of medical oncology and urology, Thomas Jefferson University, discusses the role of chemotherapy in castration-resistant prostate cancer (CRPC).

Clinical Pearls

  • Chemotherapy has been used to treat CRPC for a long time
  • Docetaxel has become a key chemotherapy agent used to treat CRPC for the last decade
  • Physicians have tried to use docetaxel with other newer targeted agents, but combining agents with docetaxel has not shown any clinical benefit